Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . March 1st, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chemotherapy - Lamivudine maintains adriamycin intensity in hepatitis B patients with lymphoma
Psychology - Hepatitis C virus-infected patients with depression tolerate citalopram
Adverse Drug Effects - APOE genotypes may influence a person's response to interferon-alpha
Fatty Liver - Genotype 3 increases the risk for steatosis in those infected with hepatitis C
Proteomics - A newly discovered mimotope could lead the way to HCV receptor antagonism
Public Health - Brazilian ex-soccer players may have spread hepatitis C with shared needles
Adverse Drug Effect - Atorvastatin causes asymptomatic elevations of liver enzyme levels
Blood Screening - Procleix Ultrio Assay clinical trials commence
Business & Finance - Small molecule drug company files registration statement for IPO
Complementary and Alternative Medicine - Hydrangeae dulcis folium suppresses liver injury in rats
Finance - Ceplene maker reports net loss for first quarter
Finance - Pharmaceutical company announces 2003 financial results
HIV/HBV Coinfection - HBV treatment can lead to recovery of virus-specific T-cell responses
Head and Neck Cancer - Hepatitis C virus infection raises the risk for oral squamous cell carcinoma
Hepatitis B Virus - Phase I study to begin for therapeutic vaccine for hepatitis
Hepatitis C Vaccine - Cucumber mosaic virus as carrier of a hepatitis C virus-derived epitope
Hepatitis C Vaccine - IL-23 induces strong immune responses in hepatitis C DNA immunization
Hepatitis C Virus - Highest therapy response rates to date seen in coinfected patients
Hepatitis C Virus - Mild infection will rapidly worsen in one in three people affected
Hepatitis Virus - Clinical trials of Procleix Ultrio Assay begin on Procleix Tigris system
Immunology - Exogenous TRAIL introduces liver cells to death and inflammation
Liver Disease - Losing weight, exercising slows progression of chronic liver problems
Mutagenesis - Binding sites keep hepatitis C virus sensitive to non-nucleoside inhibitors
Oncogenesis - Truncated hepatitis B virus X gene sequences associate with liver cancer
Oncology - The insulin-like growth factor axis encourages liver cancer formation
Phytotherapy - The garlic extract allicin defends against hepatotoxicity in vivo
Transplantation - Histology stabilizes in HCV-recurrent living donor liver transplant recipients
Viral Proteomics - Hepatitis B virus X protein uses HIF-1 alpha to stimulate angiogenesis
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
